Literature DB >> 131976

Hydrocortisone in the management of dengue shock syndrome.

M Min, T U, M Aye, T N Shwe, T Swe.   

Abstract

A total of 98 patients with dengue shock syndrome admitted into Children's Hospital from February 1973 to February 1974 were randomly selected into 2 groups. A double blind controlled trial of the efficacy of pharmacologic doses of hydrocortisone hemisuccinate was carried out. The 2 groups were confirmed to be completely matched by age, sex and severity of the disease. Nine deaths occurred out of 48 cases in the steroid group (Case Fatality Rate 18.75%) and 22 deaths out of 50 cases in the non-steroid group (Case Fatality Rate 44%), the difference being statistically significant. No significant difference was detected in fluid requirements and other morbidity pattern.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 131976

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  18 in total

1.  Effect of high dose of steroid on plateletcount in acute stage of dengue Fever with thrombocytopenia.

Authors:  K C Shashidhara; K A Sudharshan Murthy; H Basavana Gowdappa; Abhijith Bhograj
Journal:  J Clin Diagn Res       Date:  2013-07-01

Review 2.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

Review 3.  Dengue haemorrhagic fever or dengue shock syndrome in children.

Authors:  Marissa M Alejandria
Journal:  BMJ Clin Evid       Date:  2015-04-10

4.  Case Management of Dengue: Lessons Learned.

Authors:  Siripen Kalayanarooj; Alan L Rothman; Anon Srikiatkhachorn
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

Review 5.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

Review 6.  Dengue haemorrhagic fever or dengue shock syndrome in children.

Authors:  Marissa M Alejandria
Journal:  BMJ Clin Evid       Date:  2009-01-12

Review 7.  Recent advances in sepsis and septic shock.

Authors:  Praveen Khilnani; Satish Deopujari; Joe Carcillo
Journal:  Indian J Pediatr       Date:  2008-09-04       Impact factor: 1.967

8.  Corticosteroids in Pediatric Shock: A Call to Arms.

Authors:  Kusum Menon; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2015-10       Impact factor: 3.624

9.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

Authors:  Joe Brierley; Joseph A Carcillo; Karen Choong; Tim Cornell; Allan Decaen; Andreas Deymann; Allan Doctor; Alan Davis; John Duff; Marc-Andre Dugas; Alan Duncan; Barry Evans; Jonathan Feldman; Kathryn Felmet; Gene Fisher; Lorry Frankel; Howard Jeffries; Bruce Greenwald; Juan Gutierrez; Mark Hall; Yong Y Han; James Hanson; Jan Hazelzet; Lynn Hernan; Jane Kiff; Niranjan Kissoon; Alexander Kon; Jose Irazuzta; Jose Irazusta; John Lin; Angie Lorts; Michelle Mariscalco; Renuka Mehta; Simon Nadel; Trung Nguyen; Carol Nicholson; Mark Peters; Regina Okhuysen-Cawley; Tom Poulton; Monica Relves; Agustin Rodriguez; Ranna Rozenfeld; Eduardo Schnitzler; Tom Shanley; Saraswati Kache; Sara Skache; Peter Skippen; Adalberto Torres; Bettina von Dessauer; Jacki Weingarten; Timothy Yeh; Arno Zaritsky; Bonnie Stojadinovic; Jerry Zimmerman; Aaron Zuckerberg
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

10.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy
Journal:  Intensive Care Med       Date:  2004-03-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.